<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Porsch M</submitter><funding>Deutsche Forschungsgemeinschaft</funding><pagination>661-674</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6546408</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(5)</volume><pubmed_abstract>Acquired tamoxifen resistance is a persistent problem for the treatment of estrogen receptor positive, premenopausal breast cancer patients and predictive biomarkers are still elusive. We here analyzed gene expression changes in a cellular model to identify early and late changes upon tamoxifen exposure and thereby novel prognostic biomarkers. Estrogen receptor positive MCF-7 cells were incubated with 4OH-tamoxifen (10 nM) and gene expression analyzed by array hybridization during 12 weeks. Array results were confirmed by nCounter- and qRT-PCR technique. Pathway enrichment analysis revealed that early responses concerned mainly amine synthesis and NRF2-related signaling and evolved into a stable gene expression pattern within 4 weeks characterized by changes in glucuronidation-, estrogen m</pubmed_abstract><journal>RNA biology</journal><pubmed_title>Time resolved gene expression analysis during tamoxifen adaption of MCF-7 cells identifies long non-coding RNAs with prognostic impact.</pubmed_title><pmcid>PMC6546408</pmcid><funding_grant_id>KA2663/3-1</funding_grant_id><funding_grant_id>FZT118</funding_grant_id><pubmed_authors>Kalinski T</pubmed_authors><pubmed_authors>Haybaeck J</pubmed_authors><pubmed_authors>Hoffmann K</pubmed_authors><pubmed_authors>Grosse I</pubmed_authors><pubmed_authors>Nass N</pubmed_authors><pubmed_authors>Ozdemir E</pubmed_authors><pubmed_authors>Wisniewski M</pubmed_authors><pubmed_authors>Bull F</pubmed_authors><pubmed_authors>Ignatov A</pubmed_authors><pubmed_authors>Porsch M</pubmed_authors><pubmed_authors>Graf S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Time resolved gene expression analysis during tamoxifen adaption of MCF-7 cells identifies long non-coding RNAs with prognostic impact.</name><description>Acquired tamoxifen resistance is a persistent problem for the treatment of estrogen receptor positive, premenopausal breast cancer patients and predictive biomarkers are still elusive. We here analyzed gene expression changes in a cellular model to identify early and late changes upon tamoxifen exposure and thereby novel prognostic biomarkers. Estrogen receptor positive MCF-7 cells were incubated with 4OH-tamoxifen (10 nM) and gene expression analyzed by array hybridization during 12 weeks. Array results were confirmed by nCounter- and qRT-PCR technique. Pathway enrichment analysis revealed that early responses concerned mainly amine synthesis and NRF2-related signaling and evolved into a stable gene expression pattern within 4 weeks characterized by changes in glucuronidation-, estrogen m</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 May</publication><modification>2026-04-08T02:12:38.201Z</modification><creation>2025-05-18T13:33:03.27Z</creation></dates><accession>S-EPMC6546408</accession><cross_references><pubmed>30760083</pubmed><doi>10.1080/15476286.2019.1581597</doi></cross_references></HashMap>